We have conducted studies showing that the the LAR family of receptor protein tyrosine phosphatases are are binding partners for proteoglycan GAG chains. The binding of the different family members are not all the same. We have identified different regions in the extracellular domains of these molecules that bind GAG chains with different sulfation patterns. We have identified a novel binding site in Receptor Protein Tyrosine Phosphatase Sigma that binds Heparin Sulfate. In addition our data point to an additional receptor that binds bioactive CSPGs. A publication describing these results has been published. We have now demonstrated the the Lipid Phosphate Phosphatase-Related Proteins (LPPRs) can modulate neuronal adhesion and the cytoskeleton through interactions with RhoGDI that modulated both RhoA and Rac1 GTPases We have created knockout mice for the LPPR-1 and LPPR-3 and are now characterizing these mice. A paper describing these results is in preparation We have found that xylosides, compounds that are used to alter proteoglycan GAG chain composition, have significant actions at concentrations lower than those previously reported to reduce GAG chains can alter growth cone morphology. Evidence points to a novel signaling mechanism triggered by xylsides only at low concentrations.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
2018
Total Cost
Indirect Cost
Name
U.S. National Heart Lung and Blood Inst
Department
Type
DUNS #
City
State
Country
Zip Code
Jin, Jingyu; Tilve, Sharada; Huang, Zhonghai et al. (2018) Effect of chondroitin sulfate proteoglycans on neuronal cell adhesion, spreading and neurite growth in culture. Neural Regen Res 13:289-297
Katagiri, Yasuhiro; Morgan, Ashlea A; Yu, Panpan et al. (2018) Identification of novel binding sites for heparin in receptor protein-tyrosine phosphatase (RPTP?): Implications for proteoglycan signaling. J Biol Chem 293:11639-11647
Yu, Panpan; Pearson, Craig S; Geller, Herbert M (2018) Flexible Roles for Proteoglycan Sulfation and Receptor Signaling. Trends Neurosci 41:47-61
Yi, Mengni; Wei, Tianjiao; Wang, Yanxia et al. (2017) The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke. J Neuroinflammation 14:203
Shumakovich, Marina A; Mencio, Caitlin P; Siglin, Jonathan S et al. (2017) Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells. FASEB J :
Yi, Mengni; Yu, Panpan; Lu, Qin et al. (2016) KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease. Mol Cell Neurosci 76:21-32
Janecke, Andreas R; Li, Ben; Boehm, Manfred et al. (2016) The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations. Am J Med Genet A 170A:103-15
Polackwich, Robert J; Koch, Daniel; McAllister, Ryan et al. (2015) Traction force and tension fluctuations in growing axons. Front Cell Neurosci 9:417
Yu, Panpan; Agbaegbu, Chinyere; Malide, Daniela A et al. (2015) Cooperative interactions of LPPR family members in membrane localization and alteration of cellular morphology. J Cell Sci 128:3210-22
Yu, Zhihua; Yu, Panpan; Chen, Hongzhuan et al. (2014) Targeted inhibition of KCa3.1 attenuates TGF-?-induced reactive astrogliosis through the Smad2/3 signaling pathway. J Neurochem 130:41-49

Showing the most recent 10 out of 25 publications